Valuation: Tianjin Ringpu Bio-Technology Co.,Ltd.

Market Cap 7.14B 1.05B 920M 845M 788M 1.49B 100B 1.52B 10.15B 3.95B 49.25B 3.95B 3.86B 170B P/E 2026 *
16.1x
P/E 2027 * 13.9x
Enterprise Value 7.66B 1.13B 987M 907M 845M 1.6B 107B 1.63B 10.89B 4.23B 52.83B 4.24B 4.15B 182B EV / Sales 2026 *
2.03x
EV / Sales 2027 * 1.76x
Free-Float
51.96%
Yield 2026 *
1.91%
Yield 2027 * 3.07%
04-27 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-30 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-29 Tianjin Ringpu Bio-Technology Co.,Ltd. announces Annual dividend, payable on May 13, 2026 CI
03-26 Tianjin Ringpu Bio-Technology Co.,Ltd. announced that it expects to receive CNY 300 million in funding CI
11-27 Ringpu Bio-Technology Secures Registration For Feline Vaccine MT
25-10-29 Maxhealth Biotech Co. Ltd. announced that it has received CNY 400 million in funding from IDG Ventures, Shenzhen Capital Group Co., Ltd., Tianjin Ringpu Bio-Technology Co.,Ltd. CI
25-10-24 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25-08-25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
25-07-14 Ringpu Bio-Tech Forecasts Up to 70% Rise in H1 Profit MT
25-06-13 Jiangxi Twins Biotechnology Co., Ltd signed a letter of intent to acquire 67.18% stake in Hunan Sinoland Bio-Pharmacy Co., Ltd. from Tianjin Ringpu Bio-Technology Co.,Ltd. and Jingpeng Holding Group Co., Ltd for approximately CNY 115 million. CI
25-04-30 Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on November 4, 2024. CI
25-04-29 Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback announced on November 4, 2024, has closed with 6,997,751 shares, representing 1.52% for CNY 129.98 million. CI
25-04-25 Tianjin Ringpu Bio-Technology Co.,Ltd. Approves Cash Dividend on A Shares for the Year 2024, Payable on 21 May 2025 CI
1 day+2.74%
1 week+9.39%
Current month+9.01%
1 month-1.69%
3 months-10.27%
6 months-16.20%
Current year-16.20%
1 week 13.91
Extreme 13.91
15.82
1 month 13.91
Extreme 13.91
16.1
Current year 13.91
Extreme 13.91
21.51
1 year 13.91
Extreme 13.91
24.03
3 years 11.25
Extreme 11.25
28.9
5 years 11.25
Extreme 11.25
34.45
10 years 6.3
Extreme 6.3
44.41
Manager TitleAgeSince
Chief Executive Officer 53 2023-03-29
Director of Finance/CFO 51 2022-04-27
Corporate Officer/Principal 45 2020-10-26
Director TitleAgeSince
Chairman 63 2008-05-11
Director/Board Member 53 2019-12-24
Director/Board Member 51 2020-01-09
Date Insider Type Main position Quantity % Market Cap.
06-15Buy

Chief Executive Officer

500,000 0.1535%
23-05-23Buy 3,000 0.0009%
23-05-22Buy 1,000 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+2.74%+9.39%-20.52%-11.63% 1.05B
+3.24%-1.70%-53.01%-56.06% 31.36B
+3.78%+1.75%+70.77%+149.25% 12.49B
+1.56%-4.08%-13.04%+5.09% 3.84B
+0.15%-2.92%-3.91%+22.51% 3.18B
+2.93%+7.60%+53.68%+27.83% 1.98B
+0.50%+2.89%-27.86%+18.36% 1.66B
+3.61%+4.95%+18.79%+141.72% 1.35B
-1.39%-2.21%-6.23%-23.04% 941M
+2.29%+5.22%-15.20%-47.08% 940M
Average +1.94%+2.02%+0.35%+22.69% 5.88B
Weighted average by Cap. +2.90%-0.82%-13.56%+6.73%

Financials

2026 *2027 *
Net sales 3.77B 555M 485M 446M 416M 788M 52.85B 800M 5.35B 2.08B 25.98B 2.08B 2.04B 89.53B 4.26B 627M 549M 504M 470M 891M 59.75B 905M 6.05B 2.35B 29.37B 2.36B 2.3B 101B
Net income 441M 64.98M 56.8M 52.2M 48.66M 92.29M 6.19B 93.69M 627M 244M 3.04B 244M 239M 10.48B 527M 77.7M 67.93M 62.43M 58.19M 110M 7.4B 112M 749M 291M 3.64B 292M 285M 12.53B
Net Debt 519M 76.51M 66.89M 61.47M 57.3M 109M 7.29B 110M 738M 287M 3.58B 287M 281M 12.34B 337M 49.65M 43.4M 39.89M 37.18M 70.52M 4.73B 71.58M 479M 186M 2.32B 186M 182M 8.01B
Logo Tianjin Ringpu Bio-Technology Co.,Ltd.
Tianjin Ringpu Bio-Technology Co Ltd is a China-based company serving the animal health industry. The Company's main business areas are the research and development, production and sales of veterinary biological products, veterinary pharmaceutical preparations (chemicals, traditional Chinese veterinary medicines, disinfectants, and others), veterinary raw materials, veterinary functional additives, and provision of overall prevention and control of animal diseases. The Company's products include pharmaceuticals, vaccines, disinfectants, cleaning agents, and functional additives for pigs, chickens, waterfowl, cattle, sheep and pets, and others.
Employees
2,803
Date Price Change Volume
26-07-03 CN¥15.73 +2.74% 4,236,000
26-07-02 CN¥15.31 +1.80% 4,882,600
26-07-01 CN¥15.04 +4.23% 4,528,500
26-06-30 CN¥14.43 -2.89% 3,193,700
26-06-29 CN¥14.86 +3.34% 5,168,704
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
15.73CNY
Average target price
20.41CNY
Spread / Average Target
+29.75%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300119 Stock